The rating affirmation is based on Aspirus’ solid operating profitability, healthy liquidity position and strong leverage measures. The hospital also faces several challenges, including a competitive market.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Aspirus will continue to generate solid margins.
More articles on healthcare finance:
How productivity improvements could help healthcare lower prices
VSS Medical Technologies expands with Legato acquisition: 5 things to know
Capital One launches new unitranche loan program
